Western Ragweed Allergy Shots: The Plains Perennial Story
Western ragweed (Ambrosia psilostachya) is the dominant perennial Ambrosia of the Great Plains and Intermountain West — the main reason Wichita, Kansas ranked the worst US allergy city three consecutive years per AAFA. Unlike its annual cousins, it regrows from creeping rhizomes, making it nearly impossible to eradicate. Climate warming has increased perennial ragweed pollen production by up to 84% in controlled experiments.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Western Ragweedis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Western Ragweed Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to western ragweed — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of western ragweed allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of western ragweed immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of western ragweed extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for western ragweed allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing western ragweed extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription western ragweed immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat western ragweed allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Western Ragweed?
The biology, taxonomy, and clinical fingerprint of Western Ragweed — the foundation of how SCIT targets it.
Ambrosia psilostachya reproduces vegetatively via creeping root systems, reappearing in the same roadsides and fields year after year throughout the Great Plains. Artificial warming has increased its pollen production by up to 84% in controlled studies.
- Scientific name
- Ambrosia psilostachya
- Family
- AsteraceaeSunflower family
- Type
- Perennial weed pollen
- Native to
- Great Plains and Great Basin of North America
- Allergen proteins
- Amb p 5 (major) — pectate lyase, homologous to Amb a 5 and Amb t 5
- Particle size
- 16–22 µm
- Avoidance difficulty
- Nearly impossible
How Western Ragweed Allergy Presents
Symptoms by body system — useful for distinguishing Western Ragweed sensitivity from overlapping allergies and infections.
Respiratory
- Prolonged rhinorrhea from July through November in southern Plains states
- Nasal congestion that overlaps with kochia and sagebrush co-sensitization in Plains patients
- Sneezing episodes driven by high-count morning winds across open prairie
- Asthma exacerbations in Plains patients with confirmed allergic asthma
- Extended seasonal symptoms compared to eastern US due to the longer frost-free Plains season
Ocular
- Bilateral conjunctival itching and tearing during August–September peak counts
- Photophobia and eyelid puffiness during prolonged Plains exposure
- Allergic shiners from sustained seasonal inflammation across a 4–5 month season
- Symptoms worsening on windy days in open Plains landscapes
Skin
- Contact dermatitis after direct plant exposure in field or rangeland settings
- Urticaria in highly sensitized patients during peak Plains pollen events
- Perioral tingling after eating raw cantaloupe, banana, or cucumber
- Atopic dermatitis flares coinciding with the extended Plains ragweed season
Systemic
- Prolonged seasonal fatigue across the 4–5 month ragweed window in southern Plains
- Oral allergy syndrome with melon, banana, cucumber, and chamomile via Ambrosia profilin cross-reactivity
- Sleep disruption and cognitive impairment from sustained histamine load
- Reduced outdoor quality of life across the entire Plains summer-fall season
Plains patients with fall allergy face a fundamentally different exposure than someone in New York. Western ragweed is perennial — same fields, every year, longer seasons. When I see a Wichita or Denver patient, I almost always pair ragweed SCIT with sagebrush, because those two plants co-pollinate and co-sensitize across the Plains.
When & Where Western Ragweed Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: August–October in northern Plains; season extends July–November in Texas and Oklahoma· ~16–18 weeks in southern Plains; Anderegg 2021 PNAS documented some of the steepest season-lengthening trends in North America at Plains pollen stations
US Exposure Map
12 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Moderate
- MT:
- High
- ND:
- High
- MN:
- Moderate
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Moderate
- ID:
- High
- WY:
- High
- SD:
- High
- IA:
- Moderate
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Moderate
- NV:
- High
- UT:
- High
- CO:
- High
- NE:
- High
- MO:
- Moderate
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Moderate
- NM:
- Moderate
- KS:
- High
- AR:
- Moderate
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- High
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- High
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Western Ragweed Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Western ragweed cross-reacts with all other Ambrosia species via the conserved Amb p 5 / Amb a 1 pectate-lyase family, providing the scientific rationale for using standardized short-ragweed extract as the SCIT backbone; co-sensitization with Plains sagebrush and kochia is the rule rather than the exception in western-ragweed-allergic patients.
A. psilostachya is the primary component of the western-ragweed-mix clinical formulation
Amb p 5 shares strong sequence identity with Amb a 1; FDA-standardized short-ragweed extract provides dominant cross-coverage
Profilin cross-reactivity; oral allergy syndrome with cucurbit fruits
Ambrosia profilin mediates mouth tingling; worsens during Plains ragweed season
Asteraceae family; anaphylaxis cases documented — warn patients before injection course
Ragweed-Melon-Banana Syndrome (Western Ragweed)
Ambrosia psilostachya carries profilin cross-reactive allergens analogous to Amb a 8, mediating oral allergy syndrome with cucurbit fruits, banana, and Asteraceae-derived foods. Plains patients may experience these food reactions across the entire 4–5 month western-ragweed season.
Is SCIT Right for Your Western Ragweed Allergy?
Answer five questions to see how strongly your symptom profile and Plains location match the patients who benefit most from western-ragweed SCIT.
How severe are your fall allergy symptoms in the Plains or Mountain West?
The Western Ragweed SCIT Protocol
Western ragweed SCIT relies on the FDA-standardized Ambrosia artemisiifolia extract as the dose-quantified backbone, exploiting the near-complete Amb p 5 / Amb a 1 cross-reactivity; a non-standardized A. psilostachya extract is added in Plains practice when exposure or sensitization patterns specifically warrant it.
Progressive dose escalation from dilute starting concentrations toward the maintenance target. Plains allergists often schedule build-up during the winter and spring months so patients reach maintenance dose before the July onset of western ragweed season. With Curex, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand and a brief self-observation afterward. In Plains practice, sagebrush and kochia extracts are frequently included in the same or a parallel vial set — build-up for all components is coordinated.
Ongoing maintenance injections at the Amb a 1 target dose (6–24 µg per AAAAI Practice Parameters) sustain immune tolerance across the 4–5 month Plains Ambrosia season. Dose adjustments during peak August–September counts are standard. Clinical benefit accumulates across multiple complete fall seasons of western-ragweed exposure.
Patients who complete the full course typically experience sustained immune tolerance persisting years beyond the treatment course. The decision to stop is individualized based on symptom history and the severity of Plains regional exposure. Long-term follow-up data from pollen SCIT trials supports durable benefit.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Western Ragweed SCIT
Western ragweed SCIT efficacy is extrapolated from the short-ragweed evidence base via the near-complete Amb p 5 / Amb a 1 cross-reactivity; no dedicated A. psilostachya RCT exists, but Ambrosia genus immunology strongly supports the standardized short-ragweed backbone as the clinical dosing unit.
- Ambrosia genus cross-reactivity (Amb p 5 / Amb a 1)90%
- Nasal symptom reduction benchmark (extrapolated via cross-reactivity)85%
- Perennial ragweed pollen increase under warming (climate context)84%Ziska LH et al. — artificial warming of A. psilostachya plots showed up to +84% pollen production
- Pooled ragweed SCIT symptom improvement (meta-analysis)73%Frew AJ et al. 2008, Allergy 63:1107 — ragweed SCIT meta-analysis including multi-species extracts
No published RCT specifically studying western ragweed (A. psilostachya) SCIT has been identified; efficacy for Plains patients is extrapolated from the Creticos 2006 NEJM short-ragweed benchmark via the well-characterized Amb p 5 / Amb a 1 cross-reactivity and from AAAAI Practice Parameter guidance endorsing standardized short-ragweed extract as the backbone for all Ambrosia sensitization.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Western Ragweed SCIT Side Effects
Western ragweed SCIT side effects follow standard inhalant SCIT safety parameters, as the treatment backbone is the FDA-standardized short-ragweed extract used for all Ambrosia-sensitive patients.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site redness and swelling Expected, resolves within hours; ice and antihistamine management | Rate 30–50% | Mild |
Localized itching at injection site | Rate 20–40% | Mild |
Large local reaction (>5 cm) Prompts dose adjustment; does not predict systemic reactions | Rate 3–10% | Moderate |
Delayed local soreness (8–24 hours) | Rate 10–20% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Nasal or ocular flare | Rate 0.5–1% of injections | Mild |
Generalized urticaria | Rate 0.1–0.3% of injections | Moderate |
Mild asthma exacerbation Higher risk during peak Plains ragweed season (August–September); spirometry screening before injection is advisable | Rate <0.1% of injections | Moderate |
Anaphylaxis A prescribed epinephrine auto-injector is confirmed on hand and reactions typically begin within ~30 minutes, so Curex supervises the first injection from each new vial or concentration live in the Virtual Shot Room with a brief self-observation afterward | Rate <0.01% of injections | Severe |
For eligible patients Curex makes safe at-home self-administration possible: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff. The vast majority of systemic reactions occur within the first 30 minutes, so a brief self-observation is advised. Plains patients often receive multi-allergen vials (ragweed plus sagebrush plus kochia) — dose adjustments for the full vial set are managed together.
SCIT vs Alternatives for Western Ragweed
Plains patients with western ragweed allergy have four main options: SCIT (using short-ragweed backbone covering western ragweed via cross-reactivity), at-home SLIT drops, avoidance (very limited in Plains landscapes), or daily antihistamines plus nasal corticosteroids.
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | ~85% via cross-reactive short-ragweed benchmark (Creticos 2006 NEJM) | Ragwitek tablet covers western ragweed via cross-reactivity; ~27% TCS reduction | Very limited — western ragweed covers vast Plains rangelands and roadsides | Good short-term control; breakthrough common across 4–5 month Plains season |
| 5-yr cost | $3,500–$12,000 over 5 yrs | $1,500–$5,000 over 3 yrs | Low | $500–$3,000 over 5 yrs |
| Duration | 3–5 years | 3 years tablets or ongoing drops | Ongoing every season | Annual, indefinitely |
| Convenience | Self-administered weekly at home with Curex during build-up, then ongoing maintenance — no clinic visits | Daily sublingual dose at home — key advantage for Plains patients far from clinics | Indoor refuge during peak counts; HEPA filtration | Daily or as-needed |
| Safety | Rare anaphylaxis (onset within ~30 min); Curex confirms a prescribed epinephrine auto-injector on hand and supervises the first injection from each new vial or concentration live in the Virtual Shot Room | Local oral irritation; anaphylaxis very rare | No clinical risk | Antihistamine sedation possible |
| Lasting effect | Years of remission post-completion | Moderate lasting effect | No immune modification; symptoms return annually | No lasting effect |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
SCIT offers the most durable outcome for western-ragweed allergy, with the standardized short-ragweed backbone providing cross-coverage across Ambrosia species. Curex delivers that immunotherapy as a weekly shot you give yourself at home with pricing confirmed in a current program quote — a personalized serum sterile-compounded to USP <797>, the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand — covering western ragweed and sagebrush without requiring weekly travel.
What Western Ragweed SCIT Actually Costs
Western ragweed SCIT is billed under standard allergy immunotherapy codes; coverage through major insurers follows the same pathway as short-ragweed SCIT since the backbone extract is FDA-standardized. For Plains patients with high-deductible plans or long drives to the nearest clinic, Curex offers an at-home alternative: a personalized ragweed-and-sagebrush immunotherapy delivered as a self-administered weekly shot with pricing confirmed in a current program quote; confirm quote inclusions (serum, supplies, and care team, HSA/FSA eligible).
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your western ragweed allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Western Ragweed SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Western ragweed (Ambrosia psilostachya) and short ragweed (A. artemisiifolia) both carry highly similar Group 1 pectate-lyase allergens — Amb p 5 and Amb a 1 respectively — with near-complete IgE cross-reactivity. In clinical practice, this means the FDA-standardized short-ragweed extract serves as the backbone for western-ragweed SCIT in the vast majority of Plains patients, providing the same dose-quantification advantages that have made standardized short-ragweed extract the gold standard across all Ambrosia immunotherapy. A separate non-standardized A. psilostachya extract is occasionally added when a Plains patient shows predominant western-ragweed sensitization on component testing, but truly isolated A. psilostachya sensitivity without short-ragweed cross-reactivity is extremely uncommon.
Wichita was ranked the worst US allergy city by AAFA for three consecutive years (2023–2025), driven by a combination of factors that are unique to the southern Plains: western ragweed (A. psilostachya) as a dominant perennial species that covers vast agricultural landscapes and roadsides, kochia (a highly allergenic Amaranthaceae weed), and sagebrush — all of which co-pollinate from late summer through November. The Southern Plains climate is also warming faster than the national average, extending the frost-free season and adding days to the ragweed season. A. psilostachya is a perennial, meaning it cannot be eradicated from its established range by one dry or cold season — it regrows from creeping rhizomes each year regardless of winter severity. Patients in Wichita, Oklahoma City, and Kansas City face a compounded multi-allergen fall season that is longer, more intense, and increasingly climate-driven.
Yes — and perennial western ragweed (A. psilostachya) is among the most climate-sensitive of all ragweed species. Controlled warming experiments showed up to 84% more pollen production from A. psilostachya plots under artificial warming conditions. Anderegg et al. (2021, PNAS) — the most comprehensive North American pollen-climate dataset — found Plains pollen stations recorded some of the steepest season-lengthening trends on the continent. CO₂ fertilization experiments with Ambrosia species more broadly showed 2–4 times more pollen per plant as CO₂ doubles, with Amb a 1 allergen content increasing 1.6–1.8 times per grain. Wayne et al. (2002, Ann Allergy Asthma Immunol) documented that doubling CO₂ increased ragweed pollen production approximately 61%. If your Plains fall allergy has worsened over the past decade, the data confirms the trend is real and measurable.
Distance from a clinic is one of the most common barriers to traditional SCIT in rural Plains states, where an allergy clinic may be 60–100 miles away and weekly build-up visits are required. Curex was built to solve exactly this: it delivers ragweed SCIT as a weekly shot you give yourself at home, so build-up no longer requires weekly travel. Safety is preserved through a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff. A board-certified allergist evaluates whether your sensitization pattern, symptom severity, and asthma control make you a candidate for the at-home program.
Plains patients with confirmed western ragweed allergy are frequently co-sensitized to sagebrush (Artemisia tridentata), kochia (Kochia scoparia), and Russian thistle (Salsola spp.) — the three most common co-occurring fall weeds in the Great Plains and Intermountain West. Sagebrush co-pollinates with western ragweed August–October and has a different major allergen (Art v 1, a defensin-like protein) requiring a separate SCIT vial or separate SLIT formulation. Kochia and Russian thistle are Amaranthaceae weeds with their own allergen profile (Sal k 1 pectin-methylesterase) that also requires independent treatment. A comprehensive skin-test or IgE panel covering this Plains weed cluster — ragweed, sagebrush, kochia, Russian thistle — is the standard workup for a Plains fall-allergy patient before designing the SCIT vial set.
Diagnosis of western ragweed allergy begins with a detailed clinical history: fall-onset rhinitis in a Plains or Mountain-West patient with an August–November symptom pattern that has persisted over multiple years. Skin prick testing with Ambrosia psilostachya extract (or short-ragweed extract, which cross-covers western ragweed) or specific IgE blood testing (ImmunoCAP) for short-ragweed IgE and Amb a 1 component confirms sensitization. Component-resolved diagnostics for Amb a 1 are particularly valuable: a positive Amb a 1 result confirms IgE to the dominant Group 1 pectate-lyase shared across all Ambrosia species, validating the standardized short-ragweed extract as the appropriate immunotherapy backbone. A board-certified allergist can confirm via skin or blood testing whether western ragweed is the dominant sensitizing species and whether co-sensitization to sagebrush or kochia requires additional vial components.
Western ragweed carries profilin cross-reactive allergens analogous to Amb a 8 in short ragweed, which can mediate oral allergy syndrome (OAS) with cucurbit fruits, banana, chamomile, and sunflower seeds. Plains patients may experience perioral tingling or mild mouth itching when eating raw cantaloupe, banana, cucumber, or zucchini — particularly during the August–November ragweed season when pollen levels are high. The reaction typically disappears when the foods are cooked, because profilins are heat-labile. A small proportion of ragweed-allergic patients with Amb a 6 (nsLTP) sensitization may have more systemic OAS reactions that do not resolve with cooking. Chamomile tea and echinacea supplements deserve special mention — Asteraceae family homology has caused anaphylaxis in sensitized patients, and your allergist should know about these exposures before your first injection.
For Plains patients with allergic asthma triggered by western ragweed, SCIT may reduce asthma exacerbations alongside rhinitis symptoms. The AAAAI Practice Parameters and GINA guidelines both recognize SCIT as an adjunct treatment for allergic asthma when the relevant allergen — in this case, Ambrosia — is confirmed as a trigger. The benefit for asthma typically follows the same 2–3 season timeline as rhinitis improvement. Overall systemic-reaction risk is low: a large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) recorded a systemic reaction rate of just 0.16% per patient across 23,614 patients and 2,021,600 injections, with no fatalities — lower than the 3%–14% typically seen with office-based shots. However, SCIT injections should not be administered when lung function is compromised: spirometry showing FEV1 below 70% predicted is a standard contraindication to that day's dose during the Plains ragweed season. Patients with poorly controlled asthma should optimize medical management (inhaled corticosteroids, controller therapy) before beginning SCIT build-up. A board-certified allergist will assess lung function as part of the SCIT candidacy evaluation.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.